REPRODIVAC - Next-generation vaccines and diagnostics to prevent livestock reproductive diseases of worldwide impact

REPRODIVAC presented at ‘Advances and Opportunities in Agrofood and Forestry Research’, in Zaragoza, Spain, by Pilar Muñoz

During the “Advances and Opportunities in Agrofood and Forestry Research” Business Meeting held on November 28, 2024, in Zaragoza, Pilar Muñoz (CITA partner, Spain), presented the goals and applications of REPRODIVAC project.

The event, organized by CITA, brought together 150 participants, including representatives from businesses, research centres, and institutional organizations, all interested in collaboration opportunities for R&D projects in the agri-food and forestry sectors. During her talk, Muñoz highlighted how REPRODIVAC, a key research project focused on improving animal health, is developing vaccines to prevent diseases like brucellosis, which is highly relevant to the livestock sector.

The presentation of REPRODIVAC sparked significant interest not only among livestock and veterinary sector stakeholders but also from Pilar Gayán, General Director of Science and Innovation for the Government of Aragón. She showed particular interest in the project’s potential for developing new solutions to combat brucellosis, a disease that impacts both public health and livestock productivity.

This meeting proved to be an excellent opportunity to strengthen collaboration between CITA, the agrofood sector, and other entities, fostering knowledge exchange and enhancing the research and development capabilities that will lead to a more sustainable, competitive, and resilient agri-food future.

Pilar Muñoz
Pilar Muñoz Infoday 2024 Zaragoza
Pilar Muñoz
Pilar Muñoz presenting REPRODIVAC

REPRODIVAC has received funding from the European Union’s Horizon Europe research and innovation programme under Grant Agreement No. 101060813. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or other granting authorities. Neither the European Union nor the other granting authorities can be held responsible for them.

REPRODIVAC has received funding from the European Union’s Horizon Europe research and innovation programme under Grant Agreement No. 101060813. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or other granting authorities. Neither the European Union nor the other granting authorities can be held responsible for them.

Feedback